том 144 издание 1 страницы 9-12

The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series

Тип публикацииJournal Article
Дата публикации1999-01-01
SCImago Q4
WOS Q3
БС3
SJR0.213
CiteScore2.6
Impact factor1.6
ISSN10426507, 15635325, 10267719
Organic Chemistry
Biochemistry
Inorganic Chemistry
Краткое описание
Risedronate was selected for clinical development from a library of more than 200 bisphosphonate analogs for the treatment of a variety of bone diseases. It is a pyridinyl bisphosphonate and is therefore characterized by a nitrogen residue in its structure. Our studies have increased the understanding of the optimal spatial arrangement of the nitrogen and phosphonate moieties required to give the bisphosphonate molecules the geometry necessary for potent antiresorptive activity on bone. A series of aminophenylethane phosphonates have been studied to further demonstrate these geometric requirements.
Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

2
4
6
8
10
12
Russian Journal of General Chemistry
12 публикаций, 30.77%
Russian Chemical Bulletin
7 публикаций, 17.95%
Heteroatom Chemistry
6 публикаций, 15.38%
Journal of Organometallic Chemistry
5 публикаций, 12.82%
Bone
2 публикации, 5.13%
Beilstein Journal of Organic Chemistry
1 публикация, 2.56%
Tetrahedron Letters
1 публикация, 2.56%
Biomaterials
1 публикация, 2.56%
Tetrahedron
1 публикация, 2.56%
ChemMedChem
1 публикация, 2.56%
Phosphorus, Sulfur and Silicon and the Related Elements
1 публикация, 2.56%
Pharmacological Reports
1 публикация, 2.56%
2
4
6
8
10
12

Издатели

2
4
6
8
10
12
Pleiades Publishing
12 публикаций, 30.77%
Elsevier
10 публикаций, 25.64%
Springer Nature
8 публикаций, 20.51%
Wiley
7 публикаций, 17.95%
Beilstein-Institut
1 публикация, 2.56%
Taylor & Francis
1 публикация, 2.56%
2
4
6
8
10
12
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
39
Поделиться
Цитировать
ГОСТ |
Цитировать
Ebetino F. H. The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series // Phosphorus, Sulfur and Silicon and the Related Elements. 1999. Vol. 144. No. 1. pp. 9-12.
ГОСТ со всеми авторами (до 50) Скопировать
Ebetino F. H. The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series // Phosphorus, Sulfur and Silicon and the Related Elements. 1999. Vol. 144. No. 1. pp. 9-12.
RIS |
Цитировать
TY - JOUR
DO - 10.1080/10426509908546169
UR - https://doi.org/10.1080/10426509908546169
TI - The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series
T2 - Phosphorus, Sulfur and Silicon and the Related Elements
AU - Ebetino, Frank H.
PY - 1999
DA - 1999/01/01
PB - Taylor & Francis
SP - 9-12
IS - 1
VL - 144
SN - 1042-6507
SN - 1563-5325
SN - 1026-7719
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{1999_Ebetino,
author = {Frank H. Ebetino},
title = {The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series},
journal = {Phosphorus, Sulfur and Silicon and the Related Elements},
year = {1999},
volume = {144},
publisher = {Taylor & Francis},
month = {jan},
url = {https://doi.org/10.1080/10426509908546169},
number = {1},
pages = {9--12},
doi = {10.1080/10426509908546169}
}
MLA
Цитировать
Ebetino, Frank H.. “The Discovery of the Bone-Active Agent Risedronate, and Bisphosphonate Structure-Activity Considerations Including the Aminophenylethane Phosphonate Series.” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 144, no. 1, Jan. 1999, pp. 9-12. https://doi.org/10.1080/10426509908546169.
Ошибка в публикации?